Neurobiology of Aging
Neurobiology of Aging is a monthly peer-reviewed journal published by Elsevier, covering the neurobiology of aging. Founded in 1980, it publishes original research on age-related changes in the nervous system and neurodegenerative diseases, with a 2025 impact factor of 4, indexed in SCIE.《衰老神经生物学》（Neurobiology of Aging, 简称 Neurobiol. Aging）是由爱思唯尔出版的月刊同行评审期刊，涵盖衰老神经生物学。该刊创刊于 1980 年，发表神经系统年龄相关变化与神经退行性疾病的原创研究，2025 年影响因子为 4，被 SCIE 收录。
Scope
The journal's stated aim is to publish original research on the neurobiological basis of aging and age-related neurological disorders, with its official scope covering:刊物官方宗旨为发表衰老与年龄相关神经疾病的神经生物学基础原创研究，官方声明的征稿范围包括：
- Brain aging: original research on age-related changes in the structure and function of the brain, including neuronal loss, synaptic changes, and cognitive decline.脑衰老： 关于大脑结构与功能年龄相关变化的原创研究，包括神经元丢失、突触变化与认知衰退。
- Neurodegenerative diseases: studies on the pathogenesis of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis.神经退行性疾病： 关于阿尔茨海默病、帕金森病、亨廷顿病与肌萎缩侧索硬化症等神经退行性疾病发病机制的研究。
- Cellular and molecular mechanisms: research on the cellular and molecular mechanisms underlying brain aging and neurodegeneration, including oxidative stress, inflammation, protein aggregation, and mitochondrial dysfunction.细胞与分子机制： 关于脑衰老与神经退行性变细胞与分子机制的研究，包括氧化应激、炎症、蛋白质聚集与线粒体功能障碍。
- Therapeutic interventions: studies on potential therapeutic interventions for age-related neurological disorders, including neuroprotective strategies and disease-modifying treatments.治疗干预： 关于年龄相关神经疾病潜在治疗干预的研究，包括神经保护策略与疾病修饰治疗。
- Article types: the journal publishes original research articles, review articles, and short communications on the neurobiology of aging.栏目设置： 该刊发表衰老神经生物学领域的原创研究论文、综述与短讯。
History
- Founding: the journal was established in 1980 to provide a dedicated publication venue for research on the neurobiology of aging.创刊： 该刊于 1980 年创刊，为衰老神经生物学研究提供专属发表平台。
- Elsevier publication: Neurobiology of Aging is published by Elsevier, ensuring high editorial standards and broad international distribution.Elsevier 出版： 《衰老神经生物学》由爱思唯尔出版，确保高编辑标准与广泛的国际传播。
- Specialized focus: throughout its history, the journal has maintained a specialized focus on the neurobiology of aging, making it the leading journal in this interdisciplinary field.专门聚焦： 在其发展历程中，该刊始终专注于衰老神经生物学，成为该交叉学科领域的顶级期刊。
- Publication frequency: the journal publishes monthly, ensuring timely dissemination of important advances in the neurobiology of aging.出版频率： 该刊每月出版，确保衰老神经生物学重要进展的及时传播。
Editors
The journal is led by an editor-in-chief supported by senior editors and an editorial board:该刊由主编领导，资深编辑与编委会协助工作：
- Editor-in-chief: Peter R. Rapp, PhD of Baltimore, Maryland, United States, serves as the editor-in-chief.主编： 美国马里兰州巴尔的摩的彼得·R·拉普（Peter R. Rapp, PhD）担任主编。
- Senior editors: the editor-in-chief is supported by senior editors covering Alzheimer's disease and other dementias, and other major areas of aging neurobiology.资深编辑： 主编由涵盖阿尔茨海默病与其他痴呆症以及衰老神经生物学其他主要领域的资深编辑协助。
- Editorial board: the journal has a large international editorial board comprising neuroscientists and gerontologists from leading institutions worldwide.编委会： 该刊拥有大型国际编委会，成员为来自全球顶尖机构的神经科学家与老年医学专家。
- Open access option: authors can choose to publish open access in this journal, making their articles freely available to readers upon publication in exchange for an article processing charge.开放获取选项： 作者可选择在该刊发表开放获取文章，使论文发表后即向读者免费开放，并支付文章处理费。